Docking, synthesis and antiproliferative activity of N-acylhydrazone derivatives designed as combretastatin A4 analogues
dc.creator | Amaral, Daniel Nascimento do | |
dc.creator | Cavalcanti, Bruno Coêlho | |
dc.creator | Bezerra, Daniel Pereira | |
dc.creator | Ferreira, Paulo Michel Pinheiro | |
dc.creator | Castro, Rosane de Paula | |
dc.creator | Sabino, José Ricardo | |
dc.creator | Machado, Camila Maria Longo | |
dc.creator | Chammas, Roger | |
dc.creator | Pessoa, Claudia do Ó | |
dc.creator | Sant’Anna, Carlos Mauricio Rabelo | |
dc.creator | Barreiro, Eliezer Jesus de Lacerda | |
dc.creator | Lima, Lídia Moreira | |
dc.date.accessioned | 2018-07-12T15:52:38Z | |
dc.date.available | 2018-07-12T15:52:38Z | |
dc.date.issued | 2014 | |
dc.description.abstract | Cancer is the second most common cause of death in the USA. Among the known classes of anticancer agents, the microtubule-targeted antimitotic drugs are considered to be one of the most important. They are usually classified into microtubule-destabilizing (e.g., Vinca alkaloids) and microtubule-stabilizing (e.g., paclitaxel) agents. Combretastatin A4 (CA- 4), which is a natural stilbene isolated from Combretum caffrum, is a microtubule-destabilizing agent that binds to the colchicine domain on b-tubulin and exhibits a lower toxicity profile than paclitaxel or the Vinca alkaloids. In this paper, we describe the docking study, synthesis, antiproliferative activity and selectivity index of the N-acylhydrazone derivatives (5a– r) designed as CA-4 analogues. The essential structural requirements for molecular recognition by the colchicine binding site of b-tubulin were recognized, and several compounds with moderate to high antiproliferative potency (IC50 values # 18 mM and $4 nM) were identified. Among these active compounds, LASSBio-1586 (5b) emerged as a simple antitumor drug candidate, which is capable of inhibiting microtubule polymerization and possesses a broad in vitro and in vivo antiproliferative profile, as well as a better selectivity index than the prototype CA-4, indicating improved selective cytotoxicity toward cancer cells. | pt_BR |
dc.identifier.citation | AMARAL, Daniel Nascimento do; CAVALCANTI, Bruno C.; BEZERRA, Daniel P.; FERREIRA, Paulo Michel P.; CASTRO, Rosane de Paula; SABINO, José Ricardo; MACHADO, Camila Maria Longo; CHAMMAS, Roger; PESSOA, Claudia; SANT'ANNA, Carlos M. R.; BARREIRO, Eliezer J.; LIMA, Lídia Moreira. Docking, synthesis and antiproliferative activity of N-acylhydrazone derivatives designed as combretastatin A4 analogues. Plos One, San Francisco, v. 9, n. 3, e85380, 2014. | pt_BR |
dc.identifier.doi | 10.1371/journal.pone.0085380 | |
dc.identifier.issn | e- 1420-3049 | |
dc.identifier.uri | http://repositorio.bc.ufg.br/handle/ri/15395 | |
dc.language.iso | eng | pt_BR |
dc.publisher.country | Estados unidos | pt_BR |
dc.publisher.department | Instituto de Física - IF (RG) | pt_BR |
dc.rights | Acesso Aberto | pt_BR |
dc.title | Docking, synthesis and antiproliferative activity of N-acylhydrazone derivatives designed as combretastatin A4 analogues | pt_BR |
dc.type | Artigo | pt_BR |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- Artigo - Daniel Nascimento do Amaral - 2014.pdf
- Tamanho:
- 6.77 MB
- Formato:
- Adobe Portable Document Format
Licença do Pacote
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- license.txt
- Tamanho:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descrição: